Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1991-5-20
pubmed:abstractText
Two distinct patterns of neutralization were identified by comparing the neutralization curves of monoclonal antibodies (MAbs) directed at the two surface proteins, VP4 and VP7, of rhesus rotavirus. VP7-specific MAbs were able to neutralize virus efficiently, and slight increases in antibody concentration resulted in a sharp decline in infectivity. On the other hand, MAbs to VP4 proved much less efficient at neutralizing rhesus rotavirus, and the fraction of infectious virus decreased gradually throughout a wide range of antibody concentrations. MAbs directed at VP8*, the smaller trypsin cleavage fragment of VP4, were shown to efficiently prevent binding of radiolabeled virions to MA104 cell monolayers, to an extent and at concentrations comparable to those required for neutralization of infectivity. Conversely, MAbs recognizing VP7 or the larger VP4 trypsin cleavage product, VP5*, showed little or no inhibitory effect on virus binding to cells. All MAbs studied were able to neutralize rotavirus that was already bound to the surface of cells. The MAbs directed at VP8*, but not those recognizing VP5* or VP7, were shown to mediate release of radiolabeled virus from the surface of the cells. With MAbs directed at VP7, papain digestion of virus-bound antibody molecules led to an almost complete recovery of infectivity. Neutralization could be fully restored by incubation of virus-Fab complexes with anti-mouse immunoglobulin G antiserum. Neutralization with MAbs directed at VP8* proved insensitive to digestion with papain as well as to the addition of anti-immunoglobulin antibodies.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-14171601, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-176784, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-2152820, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-2153941, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-2161857, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-2303801, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-2415712, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-2422398, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-2422651, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-2431540, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-2443417, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-2470774, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-2472045, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-2538649, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-2545914, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-2578197, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-2786647, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-2830667, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-2831376, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-2832610, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-2836605, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-2836619, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-2845130, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-2983121, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-2987395, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-3001364, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-3001366, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-3001716, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-3021983, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-3029295, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-3373570, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-4068145, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-60463, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-6186073, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-6194315, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-6202836, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-6270356, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-6295955, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-6300286, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-6306918, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-6306919, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-6309179, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-7061992, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-7269235, http://linkedlifedata.com/resource/pubmed/commentcorrection/1850007-942051
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
65
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2211-9
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1991
pubmed:articleTitle
Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture.
pubmed:affiliation
Department of Medicine, Stanford University, California 94305.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S.
More...